Matzke GR - Search Results

1

Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity.

Matzke GR, Frye RF, Early JJ, Straka RJ, Carson SW. Matzke GR, et al. Pharmacotherapy. 2000 Feb;20(2):182-90. doi: 10.1592/phco.20.3.182.34775. Pharmacotherapy. 2000. PMID: 10678296 Clinical Trial.

2

An in vivo-in vitro study of cefepime and cefazolin dialytic clearance during high-flux hemodialysis.

Maynor LM, Carl DE, Matzke GR, Gehr TW, Farthing C, Farthing D, Brophy DF. Maynor LM, et al. Among authors: matzke gr. Pharmacotherapy. 2008 Aug;28(8):977-83. doi: 10.1592/phco.28.8.977. Pharmacotherapy. 2008. PMID: 18657014

3

Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.

Heintz BH, Matzke GR, Dager WE. Heintz BH, et al. Among authors: matzke gr. Pharmacotherapy. 2009 May;29(5):562-77. doi: 10.1592/phco.29.5.562. Pharmacotherapy. 2009. PMID: 19397464 Review.

4

Pharmacists and industry: guidelines for ethical interactions.

American College of Clinical Pharmacy, Hatton RC, Chavez ML, Jackson E, Maurey J, Barriere SL, Couchenour R, Evens RP, Gunning K, Hume AL, Hutchison LC, Matzke GR, Noviasky JA, Rospond RM, Kelloway JS, Stevenson JG, Vanderveen RP, Verme-Gibboney CN, Walters D. American College of Clinical Pharmacy, et al. Among authors: matzke gr. Pharmacotherapy. 2008 Mar;28(3):410-20. doi: 10.1592/phco.28.3.410. Pharmacotherapy. 2008. PMID: 18294122 No abstract available.

5

Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches.

Dowling TC, Matzke GR, Murphy JE, Burckart GJ. Dowling TC, et al. Among authors: matzke gr. Pharmacotherapy. 2010 Aug;30(8):776-86. doi: 10.1592/phco.30.8.776. Pharmacotherapy. 2010. PMID: 20653353

6

Disposition of foscarnet during peritoneal dialysis.

Alexander AC, Akers A, Matzke GR, Aweeka FT, Fraley DS. Alexander AC, et al. Among authors: matzke gr. Ann Pharmacother. 1996 Oct;30(10):1106-9. doi: 10.1177/106002809603001007. Ann Pharmacother. 1996. PMID: 8893116

7

Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents.

Matzke GR. Matzke GR. Am J Kidney Dis. 1996 Jul;28(1 Suppl 1):S63-70. doi: 10.1016/s0272-6386(96)90571-5. Am J Kidney Dis. 1996. PMID: 8669432 Review.

8

Pharmacotherapeutic consequences of recent advances in hemodialysis therapy.

Matzke GR. Matzke GR. Ann Pharmacother. 1994 Apr;28(4):512-4. doi: 10.1177/106002809402800415. Ann Pharmacother. 1994. PMID: 8038477 Review. No abstract available.

9

Clinical consequences of nonnarcotic analgesic use.

Matzke GR. Matzke GR. Ann Pharmacother. 1997 Feb;31(2):245-8. doi: 10.1177/106002809703100219. Ann Pharmacother. 1997. PMID: 9034429

10

Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment.

Matzke GR, St Peter WL, Comstock TJ, Foote EF. Matzke GR, et al. Ann Pharmacother. 2000 May;34(5):593-9. doi: 10.1345/aph.19245. Ann Pharmacother. 2000. PMID: 10852085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results